期刊文献+

含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析 被引量:10

Efficacy and safety of rituximab-contained regimen forrefractory and relapsing thrombotic thrombocytopenicpurpura: a retrospective study of 10 cases
原文传递
导出
摘要 血栓性血小板减少性紫癜(TTP)是一组以微血管病性溶血、血小板减少为主要特征的临床综合征,表现为广泛微血栓形成、组织灌注不足而引发多器官功能障碍,是一种严重威胁生命的血液科急症。特发性TTP是指在无明确基础疾病或诱发因素时患者体内因产生针对血管性血友病因子(VWF)裂解蛋白酶ADAMTSl3的自身抗体(抑制物),进而导致ADAMTSl3活性降低或缺乏,从而引起相应临床表现[1]。
作者 张炎 张路 陈苗 朱铁楠 王书杰 周道斌 Zhang Yan,Zhang Lu, Chen Miao, Zhu Tienan, Wang Shujie, Zhou Diaobin(Department of Hematology, Peking Union Medical College Hospital, Beijing 100730)
出处 《中华血液学杂志》 CAS CSCD 北大核心 2018年第10期855-858,共4页 Chinese Journal of Hematology
  • 相关文献

参考文献1

二级参考文献20

  • 1Scully M, McDonald V, Cavenagh J, et al. A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura[J]. Blood, 2011, 118(7):1746-1753.
  • 2Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura[J]. Blood, 2008, 112(1):11-18.
  • 3Shumak KH, Rock GA, Nair RC. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group[J]. Ann Intern Med, 1995, 122(8): 569-572.
  • 4Scully M, Yarranton H, Liesner R, et al. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features[J]. Br J Haematol, 2008, 142(5):819-826.
  • 5Peyvandi F, Lavoretano S, Palla R, et al. ADAMTS13 andmanti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission[J]. Haematologica, 2008, 93(2): 232-239.
  • 6Kremer Hovinga JA, L?mmle B. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura[J]. Hematology Am Soc Hematol Educ Program, 2012, 2012:610-616.
  • 7Ferrari S, Mudde GC, Rieger M, et al. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura[J]. J Thromb Haemost, 2009, 7(10): 1703-1710.
  • 8Allford SL, Hunt BJ, Rose P, et al. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias[J]. Br J Haematol, 2003, 120(4):556-573.
  • 9Blombery P, Scully M. Management of thrombotic thrombocytopenic purpura: current perspectives[J]. J Blood Med, 2014, 5:15-23.
  • 10Crawley JT, Scully MA. Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies[J]. Hematology Am Soc Hematol Educ Program, 2013, 2013:292-299.

共引文献17

同被引文献90

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部